This magnetic bead-assisted duplex-specific nuclease-specific nuclease (DSN) cleavage strategy coupled with CRISPR/Cas12a fluorescence biosensing for sensitive miR-122 detection provides a simple, sensitive, and specific platform for miR-122 detection, holding promise for liver disease-related diagnostic applications.
Abstract
MicroRNA-122 (miR-122) is a liver-enriched miRNA closely associated with hepatic disorders, making its sensitive detection crucial for liver disease-related biomarker analysis. Herein, we report a magnetic bead-assisted duplex-specific nuclease (DSN) cleavage strategy coupled with CRISPR/Cas12a fluorescence biosensing for sensitive miR-122 detection. A biotinylated DNA probe containing both a miR-122 recognition region and a Cas12a activator region was immobilized on streptavidin-modified magnetic beads. Upon target hybridization, DSN selectively cleaved the RNA/DNA duplex, releasing the DNA activator while enabling miR-122 recycling. After magnetic separation, the released activator triggered Cas12a-mediated trans-cleavage of a fluorophore-quencher-labeled ssDNA reporter, generating a fluorescence turn-on signal. Under optimized conditions, the biosensor showed a linear response from 100 fM to 10 nM, with a detection limit of 85 fM. The assay exhibited high specificity against mismatched sequences and other miRNAs, and achieved satisfactory recoveries (93.0-95.3%, RSD < 8%) in 10% human serum. This magnetic bead-assisted DSN/CRISPR-Cas12a fluorescence biosensor provides a simple, sensitive, and specific platform for miR-122 detection, holding promise for liver disease-related diagnostic applications.
The accurate detection of liver cancer-associated microRNAs (miRNAs) remains challenging due to their low abundance and high sequence homology. Herein, we report a colorimetric biosensor integrating Exo-III-assisted target recycling with a cyclization-functional DNAzyme walker for sensitive and highly specific miRNA de...
Guan-Chao Zhang, Lei Jia, Bin-Sheng Xu· In Analysis· 0 citations
Alzheimer's disease (AD) is associated with pathological changes that can occur years before the onset of clinical symptoms, highlighting the importance of sensitive biomarker detection for early diagnosis. Here, we developed a fluorescence biosensing platform based on CRISPR/Cas13a-assisted hyperbranched rolling circl...
Juan Song, Hui-Xin Yue, Chuan-Song Zhang et al.· Talanta: The International J...· 0 citations
A highly sensitive fluorescent biosensor for miRNA-34a detection by integrating magnetic separation with cascade amplification of duplex-specific nuclease (DSN) and hybridization chain reaction (HCR) and showing excellent specificity for discriminating against interfering miRNAs is developed.
Yan-Jie Zheng, Xin-Yi Zhang, Si-Yi Wang et al.· Nanomedicine: Nanotechnology...· 0 citations
Experimental results demonstrated that the developed sensing system exhibited outstanding specificity, effectively discriminating against single-base mismatches and minimizing nonspecific interference, and achieved an ultrahigh detection sensitivity down to 1.31 fM.
Jiu-Xi Cheng· Theoretical and Natural Scie...· 0 citations
CRISPR-based, amplification-free colorimetric sensing has emerged as a powerful approach for exosomal miRNA (Exo-miR) analysis, offering high specificity, simple operation, and direct visual readout suitable for point-of-care diagnostics. However, the sensitivity of existing systems is limited because conventional colo...
M. Lee, Minkyu Shin, Joungpyo Lim et al.· Nano Convergence· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.